'Patent expirations' presentation slideshows

The growing convergence of Pharma and Biotech

The Goldman Sachs Group, Inc. The growing convergence of Pharma and Biotech. BioNJ Conference : August 12, 2010. All market prices are as of August 9, 2010 close. Jami Rubin 212-357-7536 Goldman, Sachs & Co. jami.rubin@gs.com.

792 views • 30 slides

351 views • 19 slides

Global U.s Bacterial Conjunctivitis Drugs Market - Size, Share, Analysis, Trends to 2024

The U.S. bacterial conjunctivitis drugs market has been segmented based on drug classes most commonly used for the respective treatment. Based on the same, the market has been segmented into fluoroquinolones, aminoglycosides, macrolides and others. Fluoroquinolones market for bacterial conjunctivitis has been further studied for ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, gatifloxacin and besifloxacin. Aminolgycosides are further segmented into tobramycin and gentamycin. Similarly, erythromycin and azithromycin together represent the macrolides segment.

312 views • 14 slides

Industry Analysis

Industry Analysis. By: Ian, Steve, Conor, Jason and Nicholas. Top 15. Healthcare Distributors and Services. Neutral to negative investment outlook by Business Week 18% price increase (ttm, Yahoo! Finance) Healthcare demand is always high

248 views • 11 slides

Gilead Sciences, Inc. Matt Stasie Kelly Schumm

Gilead Sciences, Inc. Matt Stasie Kelly Schumm. Business Model. Research-based biopharmaceutical company Focused on life-threatening diseases: HIV/AIDS Liver disease (Hepatitis B & C) Cardiovascular Respiratory Operations: North America (55%) Europe (37%) Asia Pacific (8%).

416 views • 10 slides

Healthcare Showdown: Staffing vs. Drug Wholesaling

PM Caleb Lines M.A. Applied Economics UNM 2013. Healthcare Showdown: Staffing vs. Drug Wholesaling. A case for 50% reduction of our Healthcare Staffing ETF and a proportionate investment into Drug Wholesaling . PM Caleb Lines M.A. Applied Economics UNM 2013. Industry Driving Trends.

190 views • 9 slides

Healthcare Group

209 views • 8 slides

ADHD treatment market value to reach $9.9 billon by 2020

224 views • 6 slides